Pear Therapeutics Inc Class A PEARQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.02
- Bid/Ask
- $0.01 / $0.01
- Market Cap
- $142.74
- Volume/Avg
- 1,759 / 105,191
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Pear Therapeutics Inc is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDTs), which use software to treat diseases directly. The company's vision is to advance healthcare through the widespread use of PDTs and to be the one-stop shop for PDTs offered by Pear and other organizations that may choose to make their products available to patients, providers, and payors via its commercial platform, known as PearConnect. It features four distinct system components, consisting of PDTs for patient use, the PearMD Clinician Dashboard, an end-to-end patient service center, and a data analytics system configured to aggregate patient engagement, adherence, and clinical outcome data.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 200
- Website
- https://www.peartherapeutics.com
Valuation
|
Metric
|
PEARQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PEARQ
|
|---|---|
Quick Ratio | 1.34 |
Current Ratio | 1.48 |
Interest Coverage | −18.40 |
Quick Ratio
PEARQ
Profitability
|
Metric
|
PEARQ
|
|---|---|
Return on Assets (Normalized) | −76.26% |
Return on Equity (Normalized) | −172.20% |
Return on Invested Capital (Normalized) | −106.62% |
Return on Assets
PEARQ
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Hwmnbv | $39.4 Bil | |
VEEV
| Veeva Systems Inc Class A | Cgjndrfp | Xckc | $32.4 Bil | |
SOLV
| Solventum Corp | — | Trwgyfm | $11.1 Bil | |
MTHRF
| M3 Inc | — | Mzxrvy | $8.2 Bil | |
MTHRY
| M3 Inc ADR | — | Qkslncw | $8.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Qqcjzby | $7.5 Bil | |
HQY
| HealthEquity Inc | — | Sdnmqck | $6.8 Bil | |
RCM
| R1 RCM Inc | — | Dbzv | $5.0 Bil | |
DOCS
| Doximity Inc Class A | — | Lwwgrv | $4.4 Bil | |
EVH
| Evolent Health Inc Class A | — | Lkmjy | $3.3 Bil |